This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
The below stocks have been identified as having potential to register bigger than normal share price moves (up or down) today based on the news cited
AstraZeneca (AZN.L) – Sales in the fourth quarter fell 2% to $6.68bn, generating core earnings down 38% at 76 cents a share. Industry analysts had on average forecast sales in the quarter of $6.79bn and earnings of 82 cents a share, according to Thomson Reuters. Closing Price 4688.00p (Reuters)
BP (BP..L), Tullow Oil (TLW.L), BG Group (BG..L) and Petrofac (PFC.L) – US Light Crude slumped almost 9% yesterday as supply reached record levels according to the Energy Information Administration. Closing Prices 445.35p, 395.90p, 932.00p and 742.50p respectively (Bloomberg)
BT Group (BT.A.L) – BT has agreed definitive terms to acquire EE for £12.5bn. Closing Price 423.00p (Reuters)
Vodafone (VOD.L) – Posts better than expected Q3 sales to stem the rate of sales decline in Q3, putting the world's second biggest mobile operator in touching distance of overall revenue growth once again. Closing Price 236.50p (Reuters)
For more information on any of these individual news items, call into the trading floor
| Stock | Code | Close | High | Low |
| HSS Hire | HSS.L | 0.00% | 0.00% | -4.76% |
| Hargreaves Lansdown | HL.L | -7.50% | 0.00% | -10.42% |
| Ryanair Holdings | RYA.L | 0.10% | 1.26% | -1.47% |
| Barclays | BARC.L | 0.12% | 0.62% | -1.37% |
| Royal Bank of Scotland | RBS.L | 1.33% | 1.33% | -0.67% |
| HSBC | HSBA.L | -0.26% | 0.58% | -0.84% |
| Sky | SKY.L | 1.59% | 3.34% | 0.90% |
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance. Prepared by Michael van Dulken, Head of Research